
The global implantable biomaterials market is accounted for $79.1 billion in 2014 and estimated to grow at a compound annual growth rate (CAGR) of 6.73% reaching $133 billion in 2022. The demand metals, polymers, ceramics, and natural origin biomaterials have considerably improved since these have proven to be harmless, affordable, and dependable. Growing geriatric inhabitants worldwide has led to growing incidences of diseases such as arthritis and osteoporosis. Moreover, the aging people are also more prone to accidents and injuries, which has augmented the demand for graft transplant surgeries and medical implants. This in turn will drive the biomaterials market. The medical implants market is enhanced to counter the ever-increasing morbidity among the elderly population, thereby enhancing the biomaterials market. Technological advances introduced in the medical and healthcare industry has led to improved functionality and effectiveness of medical implants and its associated procedures. This has contributed considerably to the growth of the biomaterials market.